๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ipilimumab in melanoma

โœ Scribed by Specenier, Pol

Book ID
120171174
Publisher
Expert Reviews
Year
2012
Tongue
English
Weight
949 KB
Volume
12
Category
Article
ISSN
1473-7140

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Nivolumab plus Ipilimumab in Advanced Me
Nivolumab plus Ipilimumab in Advanced Melanoma
โœ Wolchok, Jedd D.; Kluger, Harriet; Callahan, Margaret K.; Postow, Michael A.; Ri ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 646 KB
Nivolumab plus Ipilimumab in Advanced Me
Nivolumab plus Ipilimumab in Advanced Melanoma
โœ Wolchok, Jedd D.; Kluger, Harriet; Callahan, Margaret K.; Postow, Michael A.; Ri ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 646 KB

## BACKGROUND In patients with melanoma, ipilimumab (an antibody against cytotoxic T-lymphocyteassociated antigen 4 [CTLA-4]) prolongs overall survival, and nivolumab (an antibody against the programmed death 1 [PD-1] receptor) produced durable tumor regression in a phase 1 trial. On the basis of t

Ipilimumab in the treatment of melanoma
Ipilimumab in the treatment of melanoma
โœ Trinh, Van A.; Hwu, Wen-Jen ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Informa plc ๐ŸŒ English โš– 281 KB